|
Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
RECRUITINGN/ASponsored by M.D. Anderson Cancer Center
Actively Recruiting
PhaseN/A
SponsorM.D. Anderson Cancer Center
Started2025-01-13
Est. completion2026-08-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06667427
Summary
The goal of this research study is to measure changes in patients' quality of life after surgeries that affect the facial nerve, including nerve transfer as treatment for facial paralysis.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: In order to be eligible to participate in the intervention group of this study, an individual must meet all of the following criteria: * Provision of signed and dated informed consent form * Aged 18 or greater * Patient scheduled to undergo facial nerve transfer * Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study In order to be eligible to participate in the non-intervention historical control group of this study, an individual must meet all of the following criteria: * Provision of signed and dated informed consent form * Aged 18 or greater * Previous facial surgery severing a facial nerve without graft or other form of dynamic facial nerve reconstruction within the last 5 years Exclusion Criteria: Patients known to be pregnant
Conditions2
CancerHead and Neck Cancer
Locations1 site
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, 77030
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorM.D. Anderson Cancer Center
Started2025-01-13
Est. completion2026-08-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06667427